Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the Evercore ISI
Biopharma Conference on Wednesday, November 29, 2017, in Boston. Fouad
Namouni, senior vice president, head of Oncology Development, will
answer questions about the company at 11:45 a.m. ET.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
Materials related to the presentation will be available at the same
website at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media:Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com